Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online February 2, 2007
Diabetes Care 30:980-986, 2007
DOI: 10.2337/dc06-1994
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-1994v1
30/4/980    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pittas, A. G.
Right arrow Articles by Dawson-Hughes, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pittas, A. G.
Right arrow Articles by Dawson-Hughes, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults

Anastassios G. Pittas, MD, MSC1, Susan S. Harris, DSC2, Paul C. Stark, SCD3 and Bess Dawson-Hughes, MD1,2

1 Department of Endocrinology, Diabetes, and Metabolism, Tufts–New England Medical Center, Boston, Massachusetts
2 Bone Metabolism Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts
3 Institute for Clinical Research and Health Policy Studies, Tufts–New England Medical Center, Boston, Massachusetts

Address correspondence and reprint requests to Anastassios G. Pittas, MD, M.Sc., Department of Endocrinology, Diabetes, and Metabolism, Tufts–New England Medical Center, 750 Washington St., 268, Boston, MA 02111. E-mail: apittas{at}tufts-nemc.org

OBJECTIVE—We sought to compare the effects of combined calcium and vitamin D supplementation versus placebo on blood glucose and markers of inflammation in nondiabetic adults aged ≥65 years.

RESEARCH DESIGN AND METHODS—A total of 314 Caucasian adults without diabetes received either 500 mg calcium citrate and 700 IU vitamin D3 or placebos daily for 3 years in a double-blind, randomized, controlled trial designed for bone-related outcomes. In a post hoc analysis, fasting plasma glucose (FPG), insulin sensitivity (estimated by homeostasis model assessment of insulin resistance [HOMA-IR]), plasma C-reactive protein, and interleukin-6, were measured at baseline and 3 years.

RESULTS—The effects of combined calcium–vitamin D supplementation on 3-year change in FPG depended on baseline FPG (P = 0.02 for interaction). Therefore, we conducted analyses separately in participants with normal fasting glucose (NFG) (FPG <5.6 mmol/l, n = 222) and impaired fasting glucose (IFG) (FPG 5.6–6.9 mmol/l, n = 92) at baseline. Among participants with IFG at baseline, those who took combined calcium–vitamin D supplements had a lower rise in FPG at 3 years compared with those on placebo (0.02 mmol/l [0.4 mg/dl] vs. 0.34 mmol/l [6.1 mg/dl], respectively, P = 0.042) and a lower increase in HOMA-IR (0.05 vs. 0.91, P = 0.031). In the NFG subgroup, there was no difference in the change in FPG or HOMA-IR between the two treatment arms. There were no differences in C-reactive protein or interleukin-6 between the two treatment arms in either subgroup.

CONCLUSIONS—In healthy, older adults with IFG, supplementation with calcium and vitamin D may attenuate increases in glycemia and insulin resistance that occur over time. However, our findings should be considered hypothesis generating and need to be confirmed in randomized trials specifically designed for the outcomes of interest.

Abbreviations: FPG, fasting plasma glucose • HOMA-IR, homeostasis model assessment of insulin resistance • IFG, impaired fasting glucose • NFG, normal fasting glucose • PTH, parathyroid hormone


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev., October 1, 2008; 29(6): 726 - 776.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Scragg
Vitamin D and Type 2 Diabetes: Are We Ready for a Prevention Trial?
Diabetes, October 1, 2008; 57(10): 2565 - 2566.
[Full Text] [PDF]


Home page
DiabetesHome page
N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham
Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000
Diabetes, October 1, 2008; 57(10): 2619 - 2625.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm
25-Hydroxyvitamin D and Risk of Myocardial Infarction in Men: A Prospective Study
Arch Intern Med, June 9, 2008; 168(11): 1174 - 1180.
[Abstract] [Full Text] [PDF]


Home page
cfpHome page
G. Schwalfenberg
Vitamin D and diabetes: Improvement of glycemic control with vitamin D3 repletion
Can Fam Physician, June 1, 2008; 54(6): 864 - 866.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Melamed, P. Muntner, E. D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1179 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
I. H. de Boer, L. F. Tinker, S. Connelly, J. D. Curb, B. V. Howard, B. Kestenbaum, J. C. Larson, J. E. Manson, K. L. Margolis, D. S. Siscovick, et al.
Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative
Diabetes Care, April 1, 2008; 31(4): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. C. Honeyman, S. Elkassaby, and L. C. Harrison
Seasonal Changes in Preprandial Glucose, A1C, and Blood Pressure in Diabetic Patients: Response to Liang
Diabetes Care, November 1, 2007; 30(11): e118 - e118.
[Full Text] [PDF]


Home page
Diabetes CareHome page
S. Tournis and A. Mitrakou
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults: Response to Pittas et al.
Diabetes Care, July 1, 2007; 30(7): e81 - e81.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. G. Pittas and B. Dawson-Hughes
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults: Response to Tournis and Mitrakou
Diabetes Care, July 1, 2007; 30(7): e82 - e82.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2017 - 2029.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.